- Expertise in design and development of solid dosage forms of BCS 2/4 compounds and challenging molecules; knowledgeable about biopharmaceutical challenges and regulatory requirements for BA/BE studies
- Experienced in development of conventional as well as novel dosage forms, including solid dispersions such as Hot-melt Extrusion/ Spray-drying/Co-precipitation as well as controlled release formulations
- Leadership roles in cross-functional global product development team with successful execution of formulation and process development strategies, scale-up, and manufacture of clinical, registration/validation batches
- Extensive experience on formulation and process optimization at small scale using Quality by Design (QbD) approach and successful technology/ knowledge transfer to commercial facilities.
Specialties:Formulation/Process development, formulation/process optimization with Quality by Design, Process scale- up, formulation development of poorly water soluble drugs (solid dispersion and solid solution)
Dr. Rina Chokshi has over several years of experience in formulation and process development. Rina has worked on the development of conventional as well as novel dosage forms, including solid dispersions such as hot-melt extrusion, spray-drying and co-precipitation as well as controlled release formulations.
She earned her Ph.D. from the University of Rhode Island in collaboration with Hoffman-La Roche, and went on to work for Wyeth (now Pfizer) on formulation and process optimization using Quality by Design (QbD) approaches
ExperienceUniversity of Rhode Island , usa
University of Rhode Island. Bay Campus. North Kingstown, Rhode Island.